Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin

Intensive Care Med. 2020 Apr;46(4):766-770. doi: 10.1007/s00134-019-05890-w. Epub 2020 Jan 8.

J J Rouby¹, C Sole-Lleonart^{2

3}, J Rello^{4

5

6}; European Investigators Network for Nebulized Antibiotics in Ventilator-associated Pneumonia

European Investigators Network for Nebulized Antibiotics in Ventilator-associated Pneumonia:
Antoine Monsel, Jean-Michel Constantin, Adrien Bouglé, Stijn Blot, Garyphalia Poulakou, Konstantinos Pontikis, Anna Kyriakoudi, Antonia Koutsoukou, George Dimopoulos, Christina Routsi, Kostoula Arvaniti, Jose Manuel Pereira, Timothy Felton, Jayesh Dhanani, Jason Roberts, Matteo Bassetti, Tobias Welte, Jonathan Dugernier, Pierre-François Laterre, Stephan Ehrmann, Matthieu Boisson, Olivier Mimoz, Marc Leone, Lucy B Palmer, Jérôme Pugin, Jie-Ming Qu, Ying-Gang Zhu, Xuelian Liao

¹ Multidisciplinary Intensive Care Unit, Department of Anaesthesiology and Critical Care, La Pitié-Salpêtrière Hospital, Assistance Publique Hôpitaux de Paris, Medicine Sorbonne University, Paris, France. [email protected].
² Critical Care Department, Centre Hospitalo-Universtaire Vaudois, Lausanne, Switzerland.
³ Unitat Cures Intensives, Hospital Universitari de Vic, Barcelona, Spain.
⁴ Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto Salud Carlos III, Madrid, Spain.
⁵ Vall d'Hebron Institut of Research (VHIR), Barcelona, Spain.
⁶ Anesthesiology Department, CHU Nîmes, Université Nîmes-Montepellier, Nîmes, France.

No abstract available

MeSH terms